Drug-Induced Purpura (Vascular Purpura) – Decision Support Tool

Drug-Induced Purpura (Vascular Purpura) – Interactive Decision Tool

Drug-Induced Purpura (Vascular Purpura) – Decision Support

Screen • Pattern • Timing • Labs • Causality • Case Certainty • Alternatives • Management • Summary • Regulatory

1) Patient, Drug & Exposure

2) Skin Findings & Systemic Features

Suggested pattern

–

Severity tier

–
Auto based on symptoms & labs

Immediate safety

–
Updates live
Action: Stop suspected drug. Screen for bleeding risk. Order basic labs (CBC, PT/INR, aPTT, CMP, UA).

3) Labs (enter what you have)

4) Timing – TTO & Exposure at Onset

Tip: set Start, Onset, and Last dose to auto-calculate. Second box meaning — +: stopped before onset; 0: same day; −: still taking after onset.

TTO class

–

Exposure at onset

–

Risk window fit

–
Typical risk windows (quick reference)
Platelet dysfunction (NSAIDs/SSRIs/antiplatelets): days–weeks. Anticoagulant coagulopathy (warfarin/heparin/DOAC): days–weeks (earlier if overdose). Immune vasculitis (antibiotics/antiepileptics/diuretics): 1–8 weeks (can be months). Heparin-induced thrombocytopenia (HIT): 5–10 days (earlier if prior exposure).

5) Causality – Quick Score

Causality: –

6) Case Definition Certainty (auto)

Certainty: –
Based on timing, exposure, pattern, labs, dechallenge, alternatives, evidence.
0/10

7) Alternative Explanations (check any considered)

8) Management – Auto Suggestions

    9) Pharmacovigilance (Regulatory Reporting)

    MAH expedite rules differ by region; set if known.
    What to do: —
    Where to report: —
    Timeline: —
    Attach timeline, labs, biopsy, images if available.
    Required case elements (quick checklist)
    • Identifiable patient (initials/age/sex) and reporter (name/contact/role)
    • Suspected and concomitant drugs (name, dose, route, indication, start/stop)
    • Adverse event(s): description, onset date/time, seriousness, outcome
    • Relevant tests/results (platelets, INR/aPTT, UA, biopsy, imaging)
    • Dechallenge/rechallenge, alternative causes considered, medical history

    10) Case Summary

    Disclaimer: Decision support only; does not replace clinical judgment or local protocols.